Percutaneous mitral valve repair assisted by a catheter‐based circulatory support device in a heart transplant patient

Nersesian, Gaik; Lewin, Daniel; Schoenrath, Felix; Solowjowa, Natalia; Kukucka, Marian; Falk, Volkmar; Klein, Christoph; Potapov, Evgenij; Unbehaun, Axel

doi:10.1111/jocs.15802

Cited by 7 publications

(4 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Jordan et al [43] 2022 Systematic review Lopez-Vilella et al [12] 2022 Retrospective Martinez-Sellés et al [44] 2021 Retrospective Nersesian et al [52] 2021 Case report Roth et al [11] 2021 Case report Wallen et al [15] 2020 Case report Wosten et al [53] 2020 Case report Avula et al [32] 2019 Case report Bishawi et al [13] 2019 Retrospective 542 542 52 74.7 NR Farag et al [22] 2019 Retrospective 479 16 60.7 87.5 6.1…”

Section: Patient Demographicsmentioning

confidence: 99%

“…Akleh et al [31] 2018 1 AS C: 1 Campany et al [40] 2022 2 TAVR 0/2 0 Jordan et al [43] 2022 2 TV surgery, 7 MV surgery, 5 AV surgery 3/19 15.79 Lopez-Vilella et al [12] 2022 1 TV annuloplasty, 1 PCI, 196 conservative 88/200 44 Martinez-Sellés et al [44] 2021 10 Antimicrobial therapy only, 1 MVR + Antimicrobial therapy 5/11 45.45 Nersesian et al [52] 2021 1 TMVR 0/1 0 Roth et al [11] 2021 PTVR 0/2 0 Wallen et al [15] 2020 1 TAVR 0/1 0 Wosten et al [53] 2020 1 PTVR NR Avula et al [32] 2019 1 TAVR 0/1 0 Bishawi et al [13] 2019 6 TV repair, 536 no or conservative 9/542 1.66 Farag et al [22] 2019 5 TVR (1 mechanical, 4 bioprosthetic) 7 TV repair 6 MVR (mechanical) 2/16 12.50…”

Section: Diagnosismentioning

confidence: 99%

See 1 more Smart Citation

Management options of valvular heart diseases after heart transplantation: A scoping review

Yilmaz,

Keenan

2024

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

Background: This study aimed to outline the valvular changes following heart transplantation and describe the management options to address these conditions. Methods: A literature search using EMBASE, MEDLINE, and PubMed databases was performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines in this study. Clinical studies involving patients who had their first heart transplant and articles that mentioned management for valvular heart disease were included. Treatment options were grouped into four categories: cardiac surgery other than retransplant and valve surgery, valve replacement and repairs, nonsurgical interventions, and conservative management. Results: Nine hundred and three (6.56%) patients out of 13,757 patients (10,529 males, 3,228 females; mean age: 60.3±10.4 years; range, 20 to 83 years) undergoing heart transplantation were identified with valvular disease affecting one or more valves. The mean interval between the transplant and the diagnosis of valve disease was 11.31±6.95 years. The most common valvular heart disease was tricuspid regurgitation, with 796 (94.09%) occurrences, followed by mitral regurgitation (n=22, 2.6%), aortic regurgitation (n=14, 1.65%), aortic stenosis (n=11, 1.3%), and mitral stenosis (n=3, 0.35%). Additionally, the number of surgical valve replacement and repairs (n=89) was higher than nonsurgical interventions (n=20). Conclusion: Acquired valvular heart diseases after cardiac transplantation are an infrequent clinical presentation that can cause valvular changes in the recipient. According to the extracted data, there is no sole superior management option, and more research is needed in this area.

show abstract

Section: Patient Demographicsmentioning

confidence: 99%

Section: Diagnosismentioning

confidence: 99%

Management options of valvular heart diseases after heart transplantation: A scoping review

Yilmaz,

Keenan

2024

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

show abstract

“…Most of these patients could be weaned off pMCS devices and inotropes after the TEER procedure, with improvement in mitral valve insufficiency and heart failure symptoms. Only a few patients died due to multi-organ failure [72][73][74][75][76][77][78][79][80][81][82][83][84].…”

Section: Transcatheter Edge-to-edge Repair Proceduresmentioning

confidence: 99%

Mechanical Support Strategies for High-Risk Procedures in the Invasive Cardiac Catheterization Laboratory: A State-of-the-Art Review

Groeneveld,

Swier,

Montero-Cabezas

et al. 2023

JCM

View full text Add to dashboard Cite

Thanks to advancements in percutaneous cardiac interventions, an expanding patient population now qualifies for treatment through percutaneous endovascular procedures. High-risk interventions far exceed coronary interventions and include transcatheter aortic valve replacement, endovascular management of acute pulmonary embolism and ventricular tachycardia ablation. Given the frequent impairment of ventricular function in these patients, frequently deteriorating during percutaneous interventions, it is hypothesized that mechanical ventricular support may improve periprocedural survival and subsequently patient outcome. In this narrative review, we aimed to provide the relevant evidence found for the clinical use of percutaneous mechanical circulatory support (pMCS). We searched the Pubmed database for articles related to pMCS and to pMCS and invasive cath lab procedures. The articles and their references were evaluated for relevance. We provide an overview of the clinically relevant evidence for intra-aortic balloon pump, Impella, TandemHeart and ECMO and their role as pMCS in high-risk percutaneous coronary intervention, transcatheter valvular procedures, ablations and high-risk pulmonary embolism. We found that the right choice of periprocedural pMCS could provide a solution for the hemodynamic challenges during these procedures. However, to enhance the understanding of the safety and effectiveness of pMCS devices in an often high-risk population, more randomized research is needed.

show abstract

“…In case of increasing mitral regurgitation during a reduction of Impella flow, endovascular mitral valve reconstruction can be performed under Impella support [23].…”

mentioning

confidence: 99%

Temporary Mechanical Circulatory Support in Cardiogenic Shock Patients after Cardiac Procedures: Selection Algorithm and Weaning Strategies

Nersesian,

Ott,

Fardman

et al. 2023

Life

Self Cite

View full text Add to dashboard Cite

Mechanical circulatory support has proven effective in managing postcardiotomy cardiogenic shock by stabilizing patients’ hemodynamics and ensuring adequate organ perfusion. Among the available device modalities, the combination of extracorporeal life support and a microaxial flow pump for left ventricular unloading has emerged as a valuable tool in the surgical armamentarium. In this publication, we provide recommendations for the application and weaning of temporary mechanical circulatory support in cardiogenic shock patients, derived from a consensus among leading cardiac centers in German-speaking countries.

show abstract

Percutaneous mitral valve repair assisted by a catheter‐based circulatory support device in a heart transplant patient

Cited by 7 publications

References 10 publications

Management options of valvular heart diseases after heart transplantation: A scoping review

Management options of valvular heart diseases after heart transplantation: A scoping review

Mechanical Support Strategies for High-Risk Procedures in the Invasive Cardiac Catheterization Laboratory: A State-of-the-Art Review

Temporary Mechanical Circulatory Support in Cardiogenic Shock Patients after Cardiac Procedures: Selection Algorithm and Weaning Strategies

Contact Info

Product

Resources

About